Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT)

v3.23.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Subordinate Voting Shares
Super Voting Shares
Share Capital
Accumulated Deficit
Balance, shares at Dec. 31, 2020   57,617,000 203,000    
Balance, amount at Dec. 31, 2020 $ 31,156     $ 125,540 $ (94,384)
Net loss (24,677)     0 (24,677)
Shares issued in connection with conversion of convertible debentures, shares   2,580,000      
Shares issued in connection with conversion of convertible debentures, amount 514     514 0
Issuance of shares associated with acquisitions, shares   30,641,000      
Issuance of shares associated with acquisitions, amount 43,259     43,259 0
Issuance of shares associated with subordinate voting share offering, shares   18,000,000      
Issuance of shares associated with subordinate voting share offering, amount 17,934     17,934 0
Exercise of warrants, shares   1,511,000      
Exercise of warrants, amount 718     718 0
Exercise of options, shares   167,000      
Exercise of options, amount 48     48 0
Share-based compensation expense, shares   1,290,000      
Share-based compensation expense, amount 1,355     1,355 0
Balance, shares at Dec. 31, 2021   111,806,000 203,000    
Balance, amount at Dec. 31, 2021 70,307     189,368 (119,061)
Net loss (24,564)     0 (24,564)
Issuance of shares associated with acquisitions, shares   10,000,000      
Issuance of shares associated with acquisitions, amount $ 1,800     1,800 0
Exercise of options, shares 64        
Share-based compensation expense, shares   220,000      
Share-based compensation expense, amount $ 564     564 0
Share re-purchase, shares   400,000      
Share re-purchase, amount 0     0 0
Issuance of vested RSUs, shares   144,000      
Issuance of vested RSUs, amount 10     10 0
Balance, shares at Dec. 31, 2022   121,770,000 203,000    
Balance, amount at Dec. 31, 2022 $ 48,117     $ 191,742 $ (143,625)